SMART and Treatment Interruptions: The Results Are In On January 18th, the National Institute of Allergy and Infectious Diseases announced that enrollment into a large international clinical trial comparing continuous anti-HIV therapy with episodic drug treatment guided by T-cell counts had been stopped.
Trends in HIV Diagnosis among Non-Hispanic Blacks Although HIV diagnoses have declined among most HIV risk groups, non-Hispanic blacks continue to be disproportionately affected, according to new data presented at the 13th Conference on Retroviruses and Opportunistic Infections by Dr. Tonji Durant and her colleagues at the U.S. Centers for Disease Control and Prevention.